ALCMI-006: A Prospective Biospecimen Collection Study From Patients With ROS1-Fusion Positive Tumors

NCT03497624•Addario Lung Cancer Medical Institute

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

ROS1-fusion Positive Tumor

Interventions

Biospecimens collection

Locations

United States

Locations (1)

ALCMI

San Carlos, California, United States

Key Dates

Start Date

April 23, 2018

Primary Completion Date

September 4, 2020

Completion Date

September 4, 2020

Last Updated

September 9, 2020

Sponsors

Lead Sponsor

Addario Lung Cancer Medical Institute

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 9, 2020Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions